In contrast to this finding some studies reported an increase over time in the receipt of a number of colorectal cancer surveillance procedures following treatment specifically colonoscopy, CEA testing and metastatic disease testing [28-31,37]. The gene discussed is CEACAM5; the disease is colorectal cancer.